Note 13 - Share-Based Compensation - Summary of Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands		12 Months Ended
		Dec. 31, 2025	Dec. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]
Beginning Balance, Stock Options		7,352,501
Number of Stock Options Outstanding, Granted	[1]	4,111,920
Number of Stock Options Outstanding, Exercised		(141,297)
Number of Stock Options Outstanding, Expired		(67,760)
Number of Stock Options Outstanding, Forfeited		(732,577)
Ending Balance, Stock Options		10,522,787	7,352,501
Weighted Average Exercise Price per Share, Beginning Balance		$ 6.07
Weighted Average Exercise Price per Share, Granted	[1]	2.81
Weighted Average Exercise Price per Share, Expired		7.61
Weighted Average Exercise Price per Share, Forfeited		4.76
Weighted Average Exercise Price per Share, Exercised		2.62
Weighted Average Exercise Price per Share, Ending Balance		$ 4.92	$ 6.07
Weighted Average Remaining Contractual Term (years)		7 years 9 months 14 days	7 years 10 months 2 days
Aggregate Intrinsic Value		$ 3,264,955	$ 3,818,602
Number of Stock Options Outstanding, Exercisable		5,439,089
Weighted Average Exercise Price per Share, Exercisable		$ 4.41
Weighted Average Remaining Contractual Term (years), Exercisable		6 years 7 months 28 days
Aggregate Intrinsic Value, Exercisable		$ 2,571,335
Total intrinsic value of options exercised		$ 71,188	$ 1,994,730

[1] All options granted had exercise prices equal to the closing price of the Company’s common stock on the grant date. The options were granted to employees, consultants and members of the Board of Directors and have a term of 10 years and generally vest over a four-year period.